UNSPSC 51173009: Betamethasone/lidocaine/phenylephrine

Definition: This classification is for a combination analgesic and antiinflammatory therapy. The first component, BETAMETHASONE, has US FDA Unique Ingredient Identifier of 9842X06Q6M. The second component, LIDOCAINE, has US FDA Unique Ingredient Identifier of 98PI200987. The third component, PHENYLEPHRINE, has US FDA Unique Ingredient Identifier of 1WS297W6MV.

UNSPSC 51173009 Betamethasone/lidocaine/phenylephrine is a Commodity code that does not align with recent state and local procurement activity in the source records. The code nominally identifies a specific pharmaceutical combination, but the recent opportunities posted under it span EMS vending platforms, long-term care pharmacy services, pharmaceutical network GPO participation, drug standards for forensic laboratories, naloxone distribution, and opioid settlement capital projects—none of which involve the betamethasone/lidocaine/phenylephrine formulation itself.

The mismatch between the code's intended scope and what state and local agencies are actually buying under this tag suggests either miscoding by the issuing bodies or a taxonomy misalignment in the source data. Collier County's Notice of Intent to Single Source Pediatric Emergency Standards Inc. (Handtevy) focuses on EMS drug-dosage calculation software, not pharmaceutical products. Dane County's pharmaceutical services RFP for Badger Prairie Health Care Center addresses comprehensive drug distribution and management across multiple therapeutic categories. The City of Tucson Fire Department's BLS/ALS pharmaceuticals procurement and West Texas Centers' prescription services solicitation involve broad medication portfolios and supply chain management, not targeted formulations. The procurement activity does not support pursuing opportunities under this code based on the betamethasone/lidocaine/phenylephrine formulation itself. Vendors with expertise in specific pharmaceutical combinations would be misguided to respond to these opportunities, and the code as currently tagged does not generate actionable signals for pharmaceutical manufacturers or distributors focused on this product line. If seeking state and local pharma procurement broadly—EMS supplies, long-term care pharmacy networks, or forensic drug standards—related Family or Class codes would yield more targeted opportunities.